Standard Chemical & Pharmaceutical Co Ltd
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more
Standard Chemical & Pharmaceutical Co Ltd (1720) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.057x
Based on the latest financial reports, Standard Chemical & Pharmaceutical Co Ltd (1720) has a cash flow conversion efficiency ratio of 0.057x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$510.55 Million) by net assets (NT$9.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Standard Chemical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Standard Chemical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Standard Chemical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jinhua Chunguang Technology Co Ltd
SHG:603657
|
0.121x |
|
Hunan Copote Science Technology Co Ltd
SHG:600476
|
0.282x |
|
AMPLIFY EN. CORP. NEW
F:2OQ
|
N/A |
|
Tyntek Corp
TW:2426
|
0.005x |
|
UEM Sunrise Bhd
KLSE:5148
|
0.014x |
|
Elme Communities
NYSE:ELME
|
0.018x |
|
Nam Tai Property Inc.
PINK:NTPIF
|
-0.013x |
|
Taekwang Ind
KO:003240
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$8.98 Billion | NT$1.69 Billion | 0.189x | +14.97% |
| 2023-12-31 | NT$8.14 Billion | NT$1.34 Billion | 0.164x | -0.53% |
| 2022-12-31 | NT$7.44 Billion | NT$1.23 Billion | 0.165x | +35.76% |
| 2021-12-31 | NT$6.80 Billion | NT$827.03 Million | 0.122x | -35.32% |
| 2020-12-31 | NT$4.91 Billion | NT$922.58 Million | 0.188x | +36.97% |
| 2019-12-31 | NT$4.65 Billion | NT$637.94 Million | 0.137x | +20.22% |
| 2018-12-31 | NT$4.25 Billion | NT$484.94 Million | 0.114x | -32.29% |
| 2017-12-31 | NT$4.20 Billion | NT$708.74 Million | 0.169x | +131.78% |
| 2016-12-31 | NT$4.20 Billion | NT$305.38 Million | 0.073x | -56.54% |
| 2015-12-31 | NT$3.89 Billion | NT$650.87 Million | 0.167x | +3.69% |
| 2014-12-31 | NT$3.61 Billion | NT$582.30 Million | 0.161x | +35.41% |
| 2013-12-31 | NT$3.58 Billion | NT$427.26 Million | 0.119x | -1.97% |
| 2012-12-31 | NT$3.31 Billion | NT$402.25 Million | 0.122x | -6.33% |
| 2011-12-31 | NT$3.12 Billion | NT$405.49 Million | 0.130x | +38.92% |
| 2010-12-31 | NT$2.91 Billion | NT$272.47 Million | 0.094x | -58.59% |
| 2009-12-31 | NT$2.81 Billion | NT$634.23 Million | 0.226x | -18.22% |
| 2008-12-31 | NT$2.60 Billion | NT$719.17 Million | 0.276x | +119.99% |
| 2007-12-31 | NT$2.58 Billion | NT$323.60 Million | 0.126x | -9.88% |
| 2006-12-31 | NT$2.58 Billion | NT$358.75 Million | 0.139x | -9.29% |
| 2005-12-31 | NT$2.42 Billion | NT$370.77 Million | 0.154x | -17.69% |
| 2004-12-31 | NT$1.80 Billion | NT$335.45 Million | 0.187x | +13.25% |
| 2003-12-31 | NT$1.66 Billion | NT$272.89 Million | 0.165x | +75.71% |
| 2002-12-31 | NT$1.58 Billion | NT$147.75 Million | 0.094x | -- |